"","scenario","cases","severe_disease","hosp","death","YLL"
"1","25% prioritisation"," -15,543 (-0.2%)","  -1,388 (-4.9%)","  -2,858 (-2.1%)","    -156 (-7.6%)","  -1,438 (-5.2%)"
"2","50% prioritisation"," -13,656 (-0.1%)","  -1,428 (-5%)","  -2,913 (-2.2%)","    -161 (-7.8%)","  -1,483 (-5.4%)"
"3","75% prioritisation"," -12,513 (-0.1%)","  -1,440 (-5.1%)","  -2,924 (-2.2%)","    -162 (-7.9%)","  -1,496 (-5.4%)"
"4","booster at three months (at risk only)"," -96,437 (-1%)","  -6,582 (-23.1%)"," -13,334 (-10%)","    -716 (-34.8%)","  -6,659 (-24.1%)"
"5","additional primary doses"," -23,724 (-0.2%)","  -1,488 (-5.2%)","  -3,212 (-2.4%)","    -163 (-7.9%)","  -1,525 (-5.5%)"
"6","additional booster doses","-123,242 (-1.3%)","  -6,596 (-23.2%)"," -14,051 (-10.5%)","    -697 (-33.9%)","  -6,581 (-23.8%)"
"7","broaden to <18 pregnant individuals"," -23,724 (-0.2%)","  -1,488 (-5.2%)","  -3,212 (-2.4%)","    -163 (-7.9%)","  -1,525 (-5.5%)"
